Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults
- PMID: 26957883
- PMCID: PMC4771085
Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults
Abstract
Naltrexone/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults.
Figures
References
-
- Centers for Disease Control and Prevention Defining overweight and obesity. 2012. Available at: www.cdc.gov/obesity/adult/defining.html. Accessed January 1, 2015.
-
- Centers for Disease Control and Prevention Adult obesity facts. 2014. Available at: www.cdc.gov/obesity/data/adult.html. Accessed January 1, 2015.
-
- National Cancer Institute Obesity and cancer risk. 2012. Available at: www.cancer.gov/cancertopics/factsheet/Risk/obesity. Accessed January 1, 2015.
LinkOut - more resources
Full Text Sources
Molecular Biology Databases